FDA Investigator Carolyn A Warren

Carolyn A Warren has inspections in 4 countries as of 18 Oct 2023. Carolyn A Warren has collaborated with a combinined 3357 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
18 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Germany, Italy, United States of America, Netherlands
Aaron L Dunbar, Abram A Brown, Alan R Albrecht, Alfred P Pistorio, Alison A Nicoli, Amos, Amy F Anderson, Amy L Mcintyre, Ana M Placencia, Anabel Veiga, Anthony J Ladner, Anthony L Nicoli, Anthony P Duran, April L Brown, April L Young, Aswin T Subketkaew, Baask, Bei Y He, Benedict, Benjamin J Dastoli, Billi Jom Johnson, Bradley A Servais, Brian E Thompson, Brian L Szcyubialka, Brianna R Scott, Bunce, Catherine M Vanderhoef, Christina A Castineyra, Christine M Erickson, Como, Courtney R Ingalsbe, Courtney R Tiegs, Dacia E Quick, Dale A Nyberg, Darlene L Krieger, Darren D Holaday, David B Wieneke, David J Ward, Debra D Devlieger, Demetria L Lueneburg, Dennis R Hudson, Diane T Kretschmer, Diane T Reindl, Dianna C Sonnenburg, Douglas J Snyder, Douglas R Nelson, Douglas W Atkins, Duc Minh H Nguyen, Edward A Fabiano, Edward M James, Edwin J Gorney, Elias H Wachter, Elizabeth P Mayer, Ellen C Weisensel, Emily E Harlow, Emily E Markgraf, Eric A Breselow, Fallon J Ryan, Fannie M Harrell, Frank S Sedzielarz, Garrett W Steiner, Gina M Scholze, Grant M Ruis, Greg A Abel, Gregory A Ryberg, Gregory S Larson, Gregory W Smith, Heather Akleimola Hulbert, Heather Akleimola Hurbert, Heidi J Debeck, Howard A Burmester, Ivan E Reyes, Jaclyn N Munsch, Jake T Lane, James A Beaulieu, James K Ireland, James R Evans, Jamie R Thompson, Jane E Nelson, Jasjeet K Sekhon, Jean M Trimbo, Jeffery A Hangartner, Jeffry A Bernhardt, Jennifer Alongie Vollom, Jennifer R Mathern, Jennifer S Ness, Jeremy L Tri, Jeremy R Read, Jesse P Romenesko, Jessica L Johnson, Jessica M Novak, Jocelyn M Muggli, Joel D Hustedt, John E Emmert, John T Quaife, Jon C Polzine, Jonathan G Dillon, Jonathan L Blonk, Joseph A Piechocki, Joseph J Golden, Joseph M Edwin, Julie Woodberry, Justin A Boyd, Karen M Gasperic, Karen M Jirele, Karen M Labounty, Karla J Youngberg, Katherine A Clarke Girolamo, Katherine M Taylor, Kathy Ac Girolamo, Keith C Rindahl, Kellie L Thommes, RN, Kellie L Westerbuhr, Kenneth A Libertoski, Kevin L Torgerson, Kibily D Dembele, Krista K Petersen, Kristy E Zuroski, Kyle J Mccracken, Larae M Koopman, Lauren E Merz, Lauren E Sanger, Leonardm, Liliya V Bubiy, Linda V Weyer, Mada A Tautges, Madeline T Campbell, Maf Maf, Margaret M Lubbers Solberg, Maria E Treadwell, Marie A Fadden, Marissa S Henning, Marissa S Steinhagen, Mary M Finn, Melanie C Voges, Melissa D Kalik, Melissa I Michurski, Melissaa D Kalik, Miles D Foster, Mohammed H Adam, Nicholas S Vasilakes, Paola E Lathrop, Patricia A Holmstrom, Patrick J Campbell, Peter T Erlandson, Philip S Woodward, Ralph Jerndal, Rebecca L Caulfield, Rebecca L Keller, Rebecca L Mullikin, Rebecca L Zamora, Rhonda L Meel, Robert H Claflin, Robert J Waldorf, Ronald R Ruff, Ross J Grigsby, Rostislav Servetnyk, Ryan J Benedict, Sana A Elassar, Sandra Sejdinovic, Sarah A Palmer, Scott B Laufenberg, Scott L Schenian, Seth A Abbott, Shalonda C Clifford, Shannon M Berg, Sharon K Thoma, PharmD, Sharon L Matson, Sharon M Harold, Shaun M Olson, State Agency, Steven A Skaar, Susan M Matthias, Susan M Miller, Suzanne M Crotty, Tara C Singh, Tara M Carolfi, Terrance L Scheiber, Theresa C Klaman, Thomas S Donaldson, Timothy G Philips, Tony T Yang, Traci C Kelm, Tracy A Solseng, Troy A Brenny, Victoria L Palmer, Wayne W Grundstrom, Wendy L Trefethren Grang, William E Keer, William P Fournier, Zachary P Wachlarowicz

Carolyn A Warren's Documents

Publish Date Document Type Title
May, 2009 FDA 483 Bell Pharmaceuticals, Inc. - Form 483, 2009-05-15
April, 2018 FDA 483 DairiConcepts, L.P. - Form 483, 2018-04-20
February, 2009 FDA 483 Fagron Inc - Form 483, 2009-02-11
April, 2010 EIR Perrigo Wisconsin, LLC - EIR, 2010-04-02
September, 2018 EIR Nestle Healthcare Nutrition Inc. - EIR, 2018-09-14
July, 2017 EIR Perrigo Wisconsin, LLC - EIR, 2017-07-14

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more